TGFB1 and neoplasm: Considering the broad role of TGF-β in late stage tumor progression, many approaches have been taken to inhibit TGF-β activity, including TGF-β-neutralizing antibodies [16–18], small molecular inhibitors of TGF-β RI [19] and soluble TGF-β receptor trap [20].